VERACYTE, INC. current report, 10 July 2014

Business Context and Reporting Period

This Form 8-K was filed by Veracyte, Inc. on July 10, 2014, reporting a corporate governance event. The filing details the appointment of a new executive officer effective July 10, 2014.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and associated compensation arrangements.

Material Changes

The primary material change is the appointment of Duncan T. Powell as the Company's Principal Accounting Officer and Senior Vice President, Finance, effective July 10, 2014. Mr. Powell joins from Risk Management Solutions, Inc., where he served as Senior Vice President, Finance from October 2008 to June 2014.

Guidance, Outlook, and Compensation

As part of his appointment, Mr. Powell was granted an option to purchase 45,000 shares of the Company's common stock at an exercise price of $14.92 per share. The vesting schedule is as follows:

  • 25% vests on the first anniversary of July 10, 2014.
  • The remaining shares vest monthly at a rate of 1/48th thereafter over the four-year period.

The filing states that Mr. Powell has no family relationships with directors or officers and no material interest in transactions requiring disclosure under Item 404(a) of Regulation S-K.

Investor Verification Checklist

  • Verify the exact vesting commencement date and schedule for the 45,000 stock options granted to Duncan T. Powell.
  • Confirm the exercise price of $14.92 per share relative to the market price on the grant date.
  • Review subsequent filings for any changes to the Principal Accounting Officer role or additional compensation agreements.